Information updates

Anapen® Patient Support

ANAPEN® 150, 300 and 500 adrenaline (epinephrine) autoinjectors are now available in Australia on the PBS as of 1st September 2021 in Australia. 

ANAPEN® is being made available by Allergy Concepts, which has partnered with Arrotex to ensure widespread availability in pharmacies across Australia.  

Email This email address is being protected from spambots. You need JavaScript enabled to view it. to request further information and supply of an ANAPEN® Trainer for demonstrating how to use the device. 

Allergy Concepts has aligned itself with several organisations to offer patient support services, which include:

The free pharmacy support includes:

The Anapen website  www.anapen.com.au includes links to how to use videos, education information, ASCIA and A&AA anaphylaxis resources.

Whilst the availability of another brand of adrenaline autoinjector in Australia should address any future product shortages, it is important that prescribers and their patients are familiar with both brands.

ANAPEN® is available in three dose strengths:

The range of strengths is included in the 2021 ASCIA Guidelines for Acute Management of Anaphylaxis www.allergy.org.au/hp/papers/acute-management-of-anaphylaxis-guidelines and other ASCIA anaphylaxis resources, such as the ANAPEN® version of the ASCIA Action Plan for Anaphylaxis. To access these resources visit www.allergy.org.au/anaphylaxis   

ASCIA Anaphylaxis e-training courses for Schools, Children’s Education/Care (CEC) and  Community have being updated to include information about ANAPEN® and are available at www.allergy.org.au/about-ascia/about-ascia-e-training